Assessment of Cefuroxime and Cefuroxime Clavulanic Acid Prescription Practices for Infection Management in Routine Indian Healthcare Settings: Expert Insights

Manjula S *

Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India.

Krishna Kumar M

Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India.

*Author to whom correspondence should be addressed.


Abstract

Background: Cefuroxime axetil has shown effectiveness as part of intravenous/oral sequential therapy for community-acquired pneumonia (CAP) treatment, although some countries currently lack dosage recommendations for this regimen. In addition, the perspectives of clinicians were not studied.  So, this study evaluated the prescription practice of cefuroxime, and cefuroxime+ clavulanic acid in the management of infections in routine Indian settings.

Methods: The cross-sectional survey, titled ‘Cefuroxime & Cefuroxime+Clavulanic acid in Management of Infections: Expert Perspective (CARE) Study’, utilized a 20-item, multiple-response questionnaire to gather expert opinion from specialists regarding the clinical use of cefuroxime and cefuroxime + clavulanic acid in managing infections. The survey encompassed questions about current prescription practices, clinical observations, preferences, and experiences related to the use of these antibiotics in routine settings.

Results: Among the 164 clinicians surveyed, 78% of the respondents indicated that cefuroxime was highly effective in managing lower respiratory tract infections. Additionally, 91% of the experts stated that the combination of cefuroxime and clavulanic acid was very effective in managing infections. The majority of clinicians recommended cefuroxime + clavulanic acid as the initial therapy for complicated urinary tract infections (88%), as well as first-line therapy for uncomplicated skin and soft tissue infections (45%) and community-acquired pneumonia (58%). According to 40% of the clinicians, cefuroxime + clavulanic acid was recommended as the initial therapy for 21-30% of patients suspected of methicillin-resistant Staphylococcus aureus infection. Most respondents (88%) preferred cefuroxime + clavulanic acid as the antibiotic for managing Pseudomonas aeruginosa infection.

Conclusion: The survey has emphasized the critical role of cefuroxime and cefuroxime + clavulanic acid as antibiotics in managing diverse infections. Clinicians' recognition of their efficacy and preference for combination therapy has underscored the importance of antibiotic stewardship in optimizing patient care.

Keywords: Cefuroxime, clavulanic acid, infection, respiratory tract infections, urinary tract infection


How to Cite

Manjula S, and Krishna Kumar M. 2024. “Assessment of Cefuroxime and Cefuroxime Clavulanic Acid Prescription Practices for Infection Management in Routine Indian Healthcare Settings: Expert Insights”. Asian Journal of Research in Infectious Diseases 15 (6):12-19. https://doi.org/10.9734/ajrid/2024/v15i6351.

Downloads

Download data is not yet available.

References

Grech AK, Foo CT, Paul E, Aung AK, Yu C. Epidemiological trends of respiratory tract pathogens detected via mPCR in Australian adult patients before COVID-19. BMC Infectious Diseases. 2024;24 (1):38.

Jin X, Ren J, Li R, Gao Y, Zhang H, Li J, et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. eClinical Medicine 2021;37.

Accessed On:2024 Apr 5

Available:https://www.thelancet.com/journals/eclinm/article/PIIS25895370(21)00266-2/fulltext

Waghmode R, Jadhav S, Nema V. The Burden of Respiratory Viruses and Their prevalence in different geographical Regions of India: 1970–2020. Front Microbiol 2021;12.

Accessed On:2024 Apr 5

Available:https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.723850/full

Kumar SG, Majumdar A, Kumar V, Naik BN, Selvaraj K, Balajee K. Prevalence of acute respiratory infection among under-five children in urban and rural areas of puducherry, India. J Nat Sci Biol Med. 2015;6(1):3–6.

Almutawif YA, Eid HMA. Prevalence and antimicrobial susceptibility pattern of bacterial uropathogens among adult patients in Madinah, Saudi Arabia. BMC Infectious Diseases. 2023;23(1):582.

Christy VR, Athinarayanan G, Mariselvam R, Dhasarathan P, Singh R. Epidemiology of urinary tract infection in south India. Biomedical Research and Clinical Practice. 2019;4:1-5.

Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10:888205.

Omole AE, Awosika AO, Patel P. Cefuroxime. In: Stat Pearls. Treasure Island (FL): StatPearls Publishing; 2024 Accessed On:2024 Apr 5.

Available:http://www.ncbi.nlm.nih.gov/books/NBK599503/

Scott L, Ormrod D, Goa K. Cefuroxime axetil: An updated review of its use in the management of bacterial infections. Drugs. 2001;61:1455–500.

Bax RP, Dawson AF, Mullinger BM, Dash CH. Cefuroxime in the treatment of lower respiratory tract infection. Curr Med Res Opin. 1979;5(10):772–8.

Brambilla C, Kastanakis S, Knight S, Cunningham K. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis. 1992;11(2):118–24.

Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, et al. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. Antimicrob Agents Chemother. 1995;39(11):2528–34.

Samanta TC, Bax RP, Pearson RM, Havard CW, Brumfitt W, Hamilton-Miller JM. Clinical study of cefuroxime in the treatment of lower respiratory tract infections. Curr Med Res Opin. 1980;6(7):466–71.

Adam D, Scholz H, Helmerking M. Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother. 2000;45 Suppl:23–30.

Jalil A, Niazi ID, Khan SU. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination. J Ayub Med Coll Abbottabad. 2008;20(2):28–30.

Sawant C. In-Vitro Study of Antimicrobial Activities of Five Different Commercial Fixed Dose Combination Drugs in Indian Market. Indian medical gazette. 2015;3:101–8.

De A, Tayal R, Baveja S. Comparison of sensitivity of cefuroxime-clavulanic acid combination v/s cefuroxime alone in biofilm and/or beta-lactamase-producing bacteria. European Journal of Biomedical and Pharmaceutical Sciences. 2016;3(1): 242-246.

Guo Y, Song G, Sun M, Wang J, Wang Y. Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10.

Accessed On:2024 Apr 5 Available:https://www.frontiersin.org/articles/10.3389/fcimb.2020.00107

Zubair M, Malik A, Ahmad J, Rizvi M, Farooqui K, Rizvi M. A study of biofilm production by gram-negative organisms isolated from diabetic foot ulcer patients. Biology and Medicine. 2011; 3:147–57.